TEVA Jan 2026 10.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:31PM EDT. Market open.
| Previous close | 7.45 |
| Open | 6.90 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 10.00 |
| Expiry date | 2026-01-16 |
| Day's range | 6.90 - 7.45 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.73k |
Simply Wall St.Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Teva Pharmaceutical Industries ( NYSE:TEVA ) First Quarter 2024 Results Key Financial Results Revenue: US$3.82b (up...
Investor's Business DailyTeva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Teva stock surged Wednesday after the company beat first-quarter views and unveiled promising results from its schizophrenia drug study.
Barrons.comTeva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
© 2024 Yahoo. All rights reserved.